SOUTH SAN FRANCISCO, Calif.,
Oct. 15, 2019 /PRNewswire/ -- Portola
Pharmaceuticals, Inc.® (NASDAQ: PTLA) today announced
that it will host a webcast and conference call to discuss the
Company's financial results for the quarter ended September 30, 2019, and provide a general
business overview, on Tuesday, November 5,
2019, at 4:30 p.m. ET
(1:30 p.m. PT).
Conference Call Details
The live conference call on
Tuesday, November 5, 2019, at
4:30 p.m. ET, can be accessed by
phone by calling (844) 452-6828 from the
United States and Canada or
1 (765) 507-2588 internationally and using the passcode 2980632.
The webcast can be accessed live on the Investor Relations section
of the Company's website at http://investors.portola.com. It
will be archived for 30 days following the call.
About Portola Pharmaceuticals, Inc.
Portola
Pharmaceuticals is a global, commercial-stage biopharmaceutical
company focused on the discovery, development and commercialization
of novel therapeutics that could significantly advance the fields
of thrombosis and other hematologic conditions. The Company's first
two commercialized products are Andexxa® [coagulation
factor Xa (recombinant), inactivated-zhzo], marketed in
Europe as Ondexxya®
(andexanet alfa), and Bevyxxa® (betrixaban). The company
also is advancing cerdulatinib, a SYK/JAK inhibitor being developed
for the treatment of hematologic cancers. Founded in 2003 in
South San Francisco, California,
Portola has operations in
the United States and Europe.
View original content to download
multimedia:http://www.prnewswire.com/news-releases/portola-pharmaceuticals-to-announce-third-quarter-2019-financial-results-on-tuesday-november-5-2019-300938088.html
SOURCE Portola Pharmaceuticals, Inc.®